Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 97,565 | 99,369 | 105,462 | 111,447 | 94,851 |
| Other current assets | 1,019 | 0 | 0 | 88 | 64 |
| TOTAL | $104,227 | $102,810 | $105,857 | $112,059 | $96,686 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $104,227 | $102,810 | $105,857 | $112,059 | $96,686 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,041 | 5,608 | 562 | 1,839 | 3,157 |
| Accrued Expenses | 1,115 | 991 | 1,965 | 929 | 1,536 |
| TOTAL | $7,156 | $6,599 | $2,527 | $2,768 | $4,693 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $7,156 | $6,599 | $2,527 | $2,768 | $4,693 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,198 | 6,244 | 4,563 | 4,148 | 3,970 |
| Common Shares | 1 | 1 | N/A | N/A | N/A |
| Retained earnings | -367,454 | -351,914 | -336,110 | -325,263 | -314,855 |
| TOTAL | $97,071 | $96,211 | $103,330 | $109,291 | $91,993 |
| Total Liabilities And Equity | $104,227 | $102,810 | $105,857 | $112,059 | $96,686 |